Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06815107

Risk Factors for Poor Tolerance of Ureteral Double-J Stent

The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong socio-economic impact. The objective of this study is the identification of the predictive factors of poor tolerance.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Tolerance Ureteral Double-J Stent Urinary Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Amiens-Picardie

Amiens, 80054, France

Location status: Recruiting

Location contact

Philippe De Sousa, MD

CONTACT

[email protected]

33+322455775

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient over 18 years old
  • patient who need Ureteral Double-J Stenting

Exclusion criteria

  • patient under 18 years old,
  • Iterative change,
  • understanding disorder,
  • inability to answer the questionnaire,
  • refusal of the patient,
  • long-term Ureteral Double-J Stenting (more than 6 month),
  • active cancer.

Treatment and study plan

Questionnary

Other

On day 1 of an ureteral double J stenting, each participant will receive the first USSQ questionnaire, in the French validated version. This questionnaire will be completed at home, one week after the intervention and returned at the following consultation or hospitalization.

USSQ survey

Other

if the stent is removed less than 6 months later, the second USSQ survey, in the French validated version will be given to the patient when removing the stent. This questionnaire will be completed at home one week after removal of the stent and return to the referent hospital. If the patient does not return the second questionnaire, our team may contact them by phone to complete it.

Primary outcomes

  1. tolerance score of Ureteral Double-J Stent

    Time frame: day 15

    A tolerance score of Ureteral Double-J Stent will be established using the USSQ questionnaire allowing the comparison of the symptomatology with and after ablation of the stent

  2. tolerance score of Ureteral Double-J Stent

    Time frame: 3 months

    A tolerance score of Ureteral Double-J Stent will be established using the USSQ questionnaire allowing the comparison of the symptomatology with and after ablation of the stent

Study contacts

Contact information is provided by the study sponsor or research team.

Philippe De Sousa, MD

CONTACT

[email protected]

33+322455775

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Collaborators

  • Centre Hospitalier Intercommunal de Compiègne-Noyon
  • Centre Hospitalier d'Abbeville
  • University Hospital, Caen

Registry information

Acronym: ToleJJ

Important dates

Study start
2020
Primary completion
2021
Study completion
2026
First posted
Feb 7, 2025
Registry last updated
Feb 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.